Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
Shares in the chip designer were up 0.4% at $140.69 in premarket trading. Futures tracking the benchmark S&P 500 index were ...
Strategists at HSBC led by Frank Lee lowered their price target on the shares to $110 from $200 and cut the rating to Reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback